FDA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FDA
Apr 21, 2024, 18:27 |
Insight
Aradhana Kasimsetty: Denise Sabatino and I present a review of the known risks of AAV vector-mediated liver cancer
Aradhana Kasimsetty, Doctoral Candidate at the Perelman School of Medicine, shared on LinkedIn: “With the recent…
Apr 21, 2024, 11:35 |
Insight
Samuel Kareff: Our pan-tumor analysis on the not-so-elusive HRAS mutation in solid tumors
Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…
Apr 20, 2024, 17:31 |
Blog
The U.S. FDA recently approved two CAR T-cell therapies for earlier treatment of adults with multiple myeloma - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: "PROGRESS! The U.S. FDA recently approved…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 19, 2024, 06:09 |
Blog
Dr. Gilberto Lopes shares about his work in Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on LinkedIn: "Gilberto Lopes, associate director of global oncology believes…
Apr 18, 2024, 13:58 |
Insight
Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma
Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…
Apr 17, 2024, 17:09 |
Blog
Foorquan Hashmi: Our collective commitment is embodied in the belief that 'Cancer doesn't take a day off: neither do we'
Foorquan Hashmi, Assistant Managing Editor at OncoDaily, shared a post by OncoDaily, on LinkedIn: "That's amazing news!…
Apr 16, 2024, 01:57 |
Insight
Cancer Network's top 5 articles of the week
Quoting Cancer Network on X/Twitter: "View our top 5 articles of the week: FDA Grants…
Apr 14, 2024, 22:37 |
Insight
Vivek Subbiah: Prostate cancer cases are projected to double to 2.9 million per year by 2040
Quoting Vivek Subbiah's post on X/Twitter: "Prostate cancer cases are projected to double to 2.9…
Apr 14, 2024, 03:32 |
Career
Vivek Subbiah: Sending massive congratulations to the incredible Patricia M. LoRusso for her Presidency at the American Association for Cancer Research!
Vivek Subbiah shared a post on X/Twitter: "Sending massive congratulations to the incredible AACR President,…
2
3
4
5
6
All:
138
Posts:
31 - 40
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube